ALIS Release 4.5.0

Get ready for our billing statements revamp!

 

ALIS 4.4.0.0 arrives on Monday! Going Live on April 22nd, 2019 at 12am CST.

This release will result in downtime lasting between 30 and 60 minutes. Please plan on downtime around approximately 12am CST and inform your staff. If you have any questions on how to handle this downtime, please contact the Support Team at support@medtelligent.com or your account representative.

 

Reminder! We recommend using Google Chrome for ALIS. This is especially important for the newer billing features. Other browsers will not work as well.

 

Statements when you need them

-New Statements page gives you the power to preview and generate a statement at any time
-Preview them before generating so you can send them out with confidence
-Statements can easily be created for different periods or deleted and re-generated later if corrections are needed
-See an audit of all statements generated


Two types of statements

Balance Forward option allows you to see charges and other items for the date range of your choice
Open Items option shows you any outstanding invoices on the account, plus the charges and other items in detail for the “current period” of your selection


New settings for invoice and statement comments

-Setup statement comments similar to invoice comments
-Additionally, setup a different comment for each payment method option


Drug Count: Manage Quantity page

-This page used to be called Adjust Quantity – we have changed it to Manage Quantity
-New look overall, and new filters to make it easier to see the information you need
-See a running balance of the drug’s quantity

 

Webinar Video:

 

 


The next scheduled release is June 3rd, 2019

 

Our team is always happy to help! Send your comments or questions to support@medtelligent.com.

We here at the ALIS team always strive to provide you with the best product while listening to your feedback.

We hope ALIS and all its new features will continue to make running your communities easier than ever.